Deal Tracker · Deal types
Partnership / Collaboration deals
22 partnership / collaboration deals across emerging pharma markets tracked by EPT, led by GCC, MENA, Southeast Asia & Africa. Most active: Abu Dhabi Stem Cells Center, ADCAN Pharma, Arabian Oasis & AstraZeneca. Latest: Novartis → Department of Health – Abu Dhabi (Partnership / Collaboration, 28 Oct 2026).
- Novartis → Department of Health – Abu DhabiPartnership / Collaboration · GCC · Undisclosed · 28 Oct 2026
- Institut Teknologi Bandung → IndofarmaPartnership / Collaboration · Southeast Asia · Undisclosed · 27 Oct 2026
- Roche → Iraq Ministry of HealthPartnership / Collaboration · MENA · Undisclosed · 26 Oct 2026
- Pinnacology Research & Development → Prognica LabsPartnership / Collaboration · GCC · Undisclosed · 25 Oct 2026
- Miltenyi Biomedicine → Abu Dhabi Stem Cells CenterPartnership / Collaboration · GCC · 22 Oct 2026
- Algeria — Ministry of Pharmaceutical Industry / ANPP → Kuwait — Ministry of HealthPartnership / Collaboration · MENA · 11 Oct 2026
- ADCAN Pharma → Pharma ResourcesPartnership / Collaboration · GCC · 8 Oct 2026
- Sana Pharma → National Pharmaceutical IndustriesPartnership / Collaboration · GCC · 8 Oct 2026
- Dhofar Pharmaceutical Industries → Philex PharmaceuticalsPartnership / Collaboration · GCC · 8 Oct 2026
- Aurisco Pharmaceutical → Avalon PharmaPartnership / Collaboration · MENA · Undisclosed · 6 Oct 2026
- Eva Pharma → CCL PharmaceuticalsPartnership / Collaboration · Southeast Asia · Undisclosed · 17 Sept 2026
- KyungDong Pharmaceutical → Kazakhstan Ministry of HealthPartnership / Collaboration · CIS & Central Asia · Undisclosed · 14 Sept 2026
- Pharmacare Premium → Arabian OasisPartnership / Collaboration · GCC · Undisclosed · 3 Sept 2026
- AstraZeneca → KAIMRCPartnership / Collaboration · GCC · 29 Aug 2026
- CEPI → MinapharmPartnership / Collaboration · Africa · $16.5m · 27 Aug 2026
- Northwest Biotherapeutics → SPIMACOPartnership / Collaboration · MENA · Undisclosed · 12 Jul 2026
- Novo Nordisk → Emirates Drug EstablishmentPartnership / Collaboration · GCC · Undisclosed · 8 Jun 2026
- AbbVie & Abbott → Groupe SaidalPartnership / Collaboration · MENA · Undisclosed · 13 May 2026
- CSL Seqirus → Vaccine IndustrialPartnership / Collaboration · GCC · 30 Oct 2025
- Lifera → King Faisal Specialist Hospital & Research CentrePartnership / Collaboration · MENA · Undisclosed · 28 Oct 2025
- Kelix Bio → Khalifa University of Science & Technology + Mubadala InvestmentPartnership / Collaboration · GCC · Undisclosed · 30 Apr 2024
- Huadong Medicine → JulpharPartnership / Collaboration · MENA · Undisclosed · 25 Jun 2022
Browse deals
By region
MENA (53) · GCC (48) · Africa (14) · CIS & Central Asia (10) · Southeast Asia (8) · Global (LMICs) (5) · Türkiye (4) · Global ex-US (1)
By deal type
Licensing (38) · Distribution (25) · Technology transfer / Localization (23) · M&A / Acquisition (16) · Equity / Investment (7) · Joint venture (5) · Supply / Manufacturing (5)
By company
ADCAN Pharma (11) · Mubadala Bio (8) · Hikma Pharmaceuticals (6) · Jamjoom Pharma (6) · Bio-Thera Solutions (5) · Avalon Pharma (4) · SPIMACO (4) · Groupe Saidal (4) · Department of Health – Abu Dhabi (3) · Roche (3) · Sanofi (3) · Taiba Healthcare (3) · Tabuk Pharmaceuticals (3) · Dar Al Dawa (3) · Kazakhstan Ministry of Health (3) · Galenicum (2) · DKSH (2) · Laprophan (2) · Adalvo (2) · Eva Pharma (2) · Rameda (2) · Menarini (2) · AstraZeneca (2) · MS Pharma (2) · LifePharma (2) · JCR Pharmaceuticals (2) · Gen İlaç (2) · Philex Pharmaceuticals (2) · Lotus Pharmaceutical (2) · Elpen (2) · Dhofar Pharmaceutical Industries (2) · CCL Pharmaceuticals (2) · Abdi İbrahim (2) · Nordic Pharma (2) · SaudiVax (2) · Novo Nordisk (2) · VACSERA (2) · Lifera (2) · Julphar (2)
By therapeutic area
Multi-therapy (34) · Oncology (19) · Metabolic / Diabetes (18) · Cardiovascular (13) · Vaccines (11) · Immunology / Inflammation (8) · Ophthalmology (4) · Rare / Orphan (4) · CNS / Neurology (3) · Consumer health (3) · Infectious Disease (3) · Respiratory (2) · Women's Health (2)